Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
18275 | 495 | 42.0 | 83% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
412 | 16030 | GENE DELIVERY//GENE THERAPY//POLYETHYLENIMINE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | SKIN GENE THERAPY | Author keyword | 9 | 83% | 1% | 5 |
2 | HUMAN CLOTTING FACTOR IX | Author keyword | 6 | 71% | 1% | 5 |
3 | CLOTTING FACTOR IX | Author keyword | 4 | 56% | 1% | 5 |
4 | WOUND REPAIR GENE TRANSFER | Address | 2 | 67% | 0% | 2 |
5 | LITTLE MICE | Author keyword | 2 | 50% | 1% | 3 |
6 | CUTANEOUS GENE THERAPY | Author keyword | 2 | 43% | 1% | 3 |
7 | GENET ENDOCRINOL UNIT LIM25 | Address | 1 | 100% | 0% | 2 |
8 | HUMAN CLOTTING FACTOR IX CDNA | Author keyword | 1 | 100% | 0% | 2 |
9 | IMMUNODEFICIENT DWARF MICE | Author keyword | 1 | 100% | 0% | 2 |
10 | MATRIX MEDIATED GENE DELIVERY | Author keyword | 1 | 100% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MODIFIED SKIN FIBROBLASTS | 21 | 50% | 6% | 30 |
2 | GENETICALLY MODIFIED SKIN | 18 | 83% | 2% | 10 |
3 | CULTURED EPIDERMAL KERATINOCYTES | 12 | 86% | 1% | 6 |
4 | KERATINOCYTE GENE THERAPY | 6 | 80% | 1% | 4 |
5 | NAKED DNA | 6 | 15% | 7% | 34 |
6 | ACCELERATES WOUND REPAIR | 4 | 75% | 1% | 3 |
7 | EX VIVO TRANSDUCTION | 4 | 56% | 1% | 5 |
8 | CUTANEOUS GENE DELIVERY | 3 | 100% | 1% | 3 |
9 | CANINE KERATINOCYTES | 3 | 45% | 1% | 5 |
10 | ORNITHINE DELTA AMINOTRANSFERASE | 3 | 22% | 2% | 12 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Cutaneous gene transfer for skin and systemic diseases | 2002 | 54 | 61 | 57% |
Gene therapy in wound healing: present status and future directions | 2007 | 27 | 89 | 42% |
Direct injection of naked DNA and cytokine transgene expression: implications for keratinocyte gene therapy | 2002 | 11 | 24 | 75% |
Cutaneous gene transfer and therapy: the present and the future | 2001 | 35 | 53 | 42% |
Cutaneous gene therapy | 2007 | 10 | 91 | 46% |
Combined Gene and Stem Cell Therapy for Cutaneous Wound Healing | 2011 | 22 | 90 | 17% |
Therapeutic gene delivery to the skin | 1997 | 20 | 38 | 68% |
Gene therapy and wound healing | 2007 | 22 | 128 | 27% |
Cutaneous gene therapy - an update | 2001 | 18 | 99 | 46% |
Strategies for long-term gene expression in the skin to treat metabolic disorders | 2004 | 3 | 47 | 66% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | WOUND REPAIR GENE TRANSFER | 2 | 67% | 0.4% | 2 |
2 | GENET ENDOCRINOL UNIT LIM25 | 1 | 100% | 0.4% | 2 |
3 | PLAST SURG TISSUE ENGN | 1 | 33% | 0.4% | 2 |
4 | BASIC PATHOL B3 | 1 | 50% | 0.2% | 1 |
5 | EPITHELIAL CELL DIFFERENTIAT | 1 | 50% | 0.2% | 1 |
6 | KU LEUVEN UNIV HOSP | 1 | 50% | 0.2% | 1 |
7 | PALO ALTO HEALTHCARE SYST | 1 | 50% | 0.2% | 1 |
8 | PEDIAT 3N18 | 1 | 50% | 0.2% | 1 |
9 | RETROVIRAL GENE TRANSFER SECT | 1 | 50% | 0.2% | 1 |
10 | SEZ CHIRURG PLAST RICOSTRUTTIVA | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000159214 | RETROVIRAL VECTORS//RETROVIRAL VECTOR//SELECTIVE AMPLIFIER GENE |
2 | 0.0000136877 | WOUND REPAIR AND REGENERATION//CHRONIC WOUNDS//BIOMED DIRECT |
3 | 0.0000112706 | RD ARTIFICIAL SKIN//SKIN SUBSTITUTE//DERMAL SUBSTITUTE |
4 | 0.0000104033 | REVERSE TRANSFECTION//SUBSTRATE MEDIATED DELIVERY//SUBSTRATE MEDIATED |
5 | 0.0000096775 | MOL MED GENE THER Y UNIT//GUTLESS//HELPER DEPENDENT ADENOVIRUS |
6 | 0.0000089924 | EPIDERMOLYSIS BULLOSA//DYSTROPHIC EPIDERMOLYSIS BULLOSA//COL7A1 |
7 | 0.0000074387 | SKELETAL BIOTECH//FACILITATED ENDOGENOUS REPAIR//SKELETAL BIOTECHNOL |
8 | 0.0000069557 | KERATINOCYTE GROWTH FACTOR//KGF//KERATINOCYTE GROWTH FACTOR RECEPTOR |
9 | 0.0000067526 | ADENO ASSOCIATED VIRUS//AAV//POWELL GENE THER Y |
10 | 0.0000066483 | DNA VACCINE//DNA VACCINES//DNA IMMUNIZATION |